Vasundhara Rasayans Limited (BOM:538634)
India · Delayed Price · Currency is INR 107.65
-2.20 (-2.00%)
At close: Mar 27, 2026
Vasundhara Rasayans Market Cap
Vasundhara Rasayans has a market cap or net worth of 342.13 million as of March 27, 2026. Its market cap has decreased by -55.15% in one year.
Market Cap
342.13M
Enterprise Value
340.80M
Revenue
315.86M
Ranking
n/a
PE Ratio
9.21
Stock Price
107.65
Market Cap Chart
Since January 13, 2015, Vasundhara Rasayans's market cap has increased from 41.32M to 342.13M, an increase of 728.08%. That is a compound annual growth rate of 20.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 342.13M | -36.71% |
| Dec 31, 2025 | 540.61M | -41.45% |
| Dec 31, 2024 | 923.27M | 47.09% |
| Dec 29, 2023 | 627.69M | 50.94% |
| Dec 30, 2022 | 415.87M | -3.86% |
| Dec 31, 2021 | 432.55M | 69.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kimia Biosciences | 1.20B |
| Tyche Industries | 1.07B |
| Resonance Specialties | 966.12M |
| Krebs Biochemicals & Industries | 940.69M |
| Bacil Pharma | 660.96M |
| Alfavision Overseas (India) | 404.79M |
| Venmax Drugs and Pharmaceuticals | 300.00M |
| Crestchem | 250.62M |